Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Oncolytic vaccinia virus carrying tachypleus tridentatus lectin gene, and construction method and application thereof

A vaccinia virus, construction method technology, applied in the application, virus, genetic engineering and other directions, to achieve the effect of simplifying the construction technology route, high repeatability, and improving the level of replication

Active Publication Date: 2019-12-13
HANGZHOU GONGCHU BIOTECH CO LTD
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, there is no related research on the application of TTL in the preparation of anti-tumor drugs, and there is no research on the synergistic recombination of Limulus agglutinin gene and oncolytic vaccinia virus for anti-tumor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oncolytic vaccinia virus carrying tachypleus tridentatus lectin gene, and construction method and application thereof
  • Oncolytic vaccinia virus carrying tachypleus tridentatus lectin gene, and construction method and application thereof
  • Oncolytic vaccinia virus carrying tachypleus tridentatus lectin gene, and construction method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Example 1: Construction and identification of oncolytic vaccinia virus oncoVV-TTL

[0037] 1. Insert the gene sequence (SEQ ID NO: 1) of Tachypleus tridentatus lectin (TTL) into pCB plasmid through Xba I and Bgl II sites to obtain pCB-TTL plasmid.

[0038] pCB-TTL plasmid map such as figure 1 shown. Among them, vTK-L and vTK-R, through homologous recombination with the thymidine kinase TK region of the wild-type virus, insert foreign genes into the TK region and cause TK deletion at the same time. In addition, the plasmid also carries the xanthine-guanine phoshporibosyl transferase (gpt) gene as a screening gene, and the gpt gene is derived from Escherichia coli, viruses or cells in the presence of mycophenolic acid (MPA) , because MPA can block the synthesis of guanine, so that the virus or cell can not synthesize nucleic acid normally and die. In the presence of the gpt gene, cells or viruses can use hypoxanthine (hypoxanthine) and xanthine (xanthine) to synthesize...

Embodiment 2

[0057] Example 2: In vitro inhibitory effect of oncoVV-TTL on various tumor cells detected by MTT method

[0058] In this experiment, liver cancer cells BEL-7404 and MHCC97-H, colorectal cancer cells HT-29 and glioma cells U251MG were selected, respectively, according to 5×10 3 Inoculate into a 96-well plate at a density of 96 wells, add 90 μL of cell culture medium to each well and culture overnight, add 2MOI or 10MOI oncoVV-TTL virus respectively, set up 6 replicate wells, the experimental control group is cells without virus, and the blank group is Culture medium without cells.

[0059] 37°C, 5% CO 2 For culture, three time gradients of 24h, 48h, and 72h were set, and 20 μL of MTT solution (5 mg / mL) was added to each well in the dark at the corresponding time point. The incubator was left to stand for 4 hours, and after absorbing the culture solution of each group, 150 μL of dimethyl sulfoxide was added to each well, and placed on a shaker for 10 minutes to fully dissolve...

Embodiment 3

[0062] Example 3: The replication level of oncolytic vaccinia virus oncoVV-TTL in tumor cells is significantly higher than that of control virus oncoVV

[0063] The tumor cells BEL-7404 or MHCC97-H were divided into 5×10 3 The density per well was inoculated into a 96-well plate, 90 μL of cell culture medium was added to each well and cultured overnight, 5 MOI of oncoVV-TTL virus or control virus oncoVV was added respectively, and more than 3 replicate wells were set for each time gradient. The cells were collected together with the culture medium, and the replication efficiency of oncoVV-TTL and the control virus oncoVV in the tumor cells was detected by the TCID50 method (half tissue culture infection dose).

[0064] Test results such as image 3 Shown: Compared with the control group, the replication efficiency of the experimental group oncoVV-TTL virus in tumor cells MHCC97-H and BEL-7404 was significantly higher than that of the control virus oncoVV.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention relates to the technical field of biomedical engineering, and provides an oncolytic vaccinia virus carrying a tachypleus tridentatus lectin gene, and a construction method and an application thereof. The oncolytic vaccinia virus carries the tachypleus tridentatus lectin gene, and a DNA sequence of the tachypleus tridentatus lectin gene is shown as SEQ ID NO: 1; the construction method of the oncolytic vaccinia virus comprises the following two steps: (A) inserting gene sequences of tachypleus tridentatus lectin into pCB plasmids through Xba I and Bgl II loci to obtain pCB-TTL plasmids; and (B) recombining the pCB-TTL plasmid and the vaccinia virus in cells, after screening and identifying, obtaining the oncolytic vaccinia virus carrying the tachypleus tridentatus lectin gene.The oncolytic vaccinia virus disclosed by the invention not only has a remarkable inhibition effect on various tumor cells, but also can remarkably inhibit the antiviral factor level of the tumor cells and remarkably improve the ERK phosphorylation level, and is beneficial to virus replication; and in addition, the replication level of the oncolytic vaccinia virus carrying the TTL gene is also remarkably improved.

Description

technical field [0001] The invention relates to the technical field of biomedical engineering, in particular to an oncolytic vaccinia virus carrying a limulus agglutinin gene, a construction method and application thereof. Background technique [0002] Oncolytic viruses refer to therapeutically valuable viruses that can selectively infect and damage tumor tissues. Since the first report in 1991 that herpes simplex virus (HSV) lacking thymidine kinase (TK) was used to treat glioblastoma in mice, oncolytic viruses belonging to at least 10 virus families have entered Clinical trials, including Adenovirus, Coxackie virus, Herpes simplex virus, Measles virus, Newcastle disease virus, Parvovirus, Poliovirus ( Poliovirus), Reovirus, Vaccinia virus, and Vesicular stomatitis virus. Overall, oncolytic viruses have shown considerable safety and efficacy in clinical trials. [0003] Vaccinia virus is a double-stranded DNA virus with an envelope. It has become a kind of vaccine due to...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N7/01C12N15/12A61K35/768A61K38/17A61P35/00
CPCC12N7/00C07K14/43504A61K35/768A61K38/1767A61P35/00C12N2710/24021C12N2710/24032Y02A50/30
Inventor 李恭楚
Owner HANGZHOU GONGCHU BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com